There persists a divide in mental health carewhere longacting injectable LAI antipsychotics can improve outcomes yet healthcare professionals do not offer these therapies enough to their patients with schizophrenia Learn what steps can be taken to improve LAI antipsychotic utilization in this vulnerable patient population
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/neurology/lai-antipsychotics-and-sdoh/25075-45253
- Start Date: 2024-07-30 05:00:00
- End Date: 2024-07-30 05:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Indivior Inc - Amount: 2272.72 - Is Kind Support: False Source: Otsuka America Pharmaceutical, Inc. - Amount: 4545.45 - Is Kind Support: False Source: Teva Pharmaceutical Industries - Amount: 22727.27 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest